Expression of HER-2/neu oncoprotein, DNA-ploidy and S-phase fraction in advanced ovarian cancer
- 1 August 1993
- journal article
- Published by Elsevier in International Journal of Gynecologic Cancer
- Vol. 3 (5) , 271-278
- https://doi.org/10.1046/j.1525-1438.1993.03050271.x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Flow cytometric evaluation of epithelial ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1990
- Expression of the p185 encoded by her2 oncogene in normal and transformed human tissuesInternational Journal of Cancer, 1990
- Ploidy, proliferative activity and prognosis. DNA flow cytometry of solid tumorsCancer, 1990
- The prognostic significance of nuclear DNA content in malignant epithelial tumors of the ovaryCancer, 1990
- Flow-cytometric prognostic factors for the survival of patients with ovarian carcinoma: A 5-year follow-up studyGynecologic Oncology, 1989
- Prognostic significance of dna index, multiploidy, and S-phase fraction in ovarian cancerCancer, 1988
- Tumor DNA content as a prognostic feature in advanced epithelial ovarian carcinomaGynecologic Oncology, 1987
- Tumor ploidy as a major prognostic factor in advanced ovarian cancerCancer, 1987
- The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigenNature, 1984
- Interobserver variability in the interpretation of epithelial ovarian cancerGynecologic Oncology, 1984